Home›Stock Screener›Sanofi

Sanofi Share Price Today | Stock Price & Sanofi Share Screener

SANOFI Pharmaceuticals & Biotechnology
Live Share Price NSE
₹3231.80
▲ 7.90 (0.25%)
2026-11-18 00:00:00
Live Share Price BSE
₹3231.65
▲ 4.35 (0.13%)
2026-11-18 00:00:00

As of November 18, 2026, the live Sanofi share price (NSE: SANOFI) is ₹3,231.80 on NSE and ₹3,231.65 on BSE, up 0.25% from the previous close, with shares trading between ₹3,184.70 and ₹3,243.70 in today's trading session, and a 52-week range of ₹2,772.80–₹4,568.80. Track SANOFI market cap trends to gauge the company's total market size. Use the Sanofi stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Sanofi opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹539 and net income of ₹120, with EBITDA of ₹175, an operating margin of 32.0% and a profit margin of 22.3%.

Sanofi Market Cap ₹7,443.04 Cr.
SANOFI P/E Ratio (TTM) 20.40
Sanofi P/B Ratio 9.00
EPS (TTM) ₹179.46
Dividend Yield 2.33%
Debt to Equity 0.02
SANOFI 52 Week High ₹4568.80
Sanofi 52 Week Low ₹2772.80
Operating Margin 32.00%
Profit Margin 22.26%
SANOFI Revenue (TTM) ₹539.00
EBITDA ₹175.00
Net Income ₹120.00
Total Assets ₹1,612.00
Total Equity ₹861.00

Sanofi Share Price Chart

Track the current stock price of Sanofi with an interactive chart. Analyse SANOFI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Sanofi stock quote in one place.

The quote of ₹3,231.80 sits between the 52-week low of ₹2,772.80 and the 52-week high of ₹4,568.80, and the latest session moved 0.25% from the previous close.

Sanofi Company Profile - Fundamental Screener

Screen Sanofi company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SANOFI shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, with Rahul Bhatnagar listed as chairperson or CEO, and it trades under ISIN INE058A01010.

Business Overview

Sanofi India Limited is a pharmaceutical company primarily engaged in manufacturing and trading drugs and pharmaceuticals. It operates manufacturing facilities in Goa and Ankleshwar, Gujarat, and sells products through independent distributors mainly in India. The company focuses on five therapeutic areas: diabetes, epilepsy, cardiology, allergy, and pain care. Key products...more

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

Chairperson/CEO Rahul Bhatnagar
ISIN INE058A01010

Sanofi Balance Sheet Screener

Screen SANOFI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2024, total assets were ₹1,612, down from ₹1,715 in 2023.

Latest statistics put total assets at ₹1,612 and shareholder funds at ₹861, with a leverage ratio of 0.02.

Item 2024 2023

Assets

Total Assets 1,612 1,715
Current Assets 0 0
Fixed Assets 313 315

Liabilities

Total Liabilities 0 0
Current Liabilities 32 48
Non-Current Liabilities 0 0

Shareholders' Equity

Total Equity 861 1,015
Share Capital 23 23
Reserves & Surplus 838 992

Sanofi Income Statement Screener - Profit & Revenue Analysis

Screen Sanofi income statement and profit fundamentals. Analyze SANOFI quarterly results. Sanofi reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2025-Mar, revenue was ₹539 and net profit was ₹120, equal to earnings per unit of ₹51.89, at an operating margin of 32%.

In that period expenses were ₹364, interest cost ₹0 and tax ₹46. The next period listed, 2024-Dec, shows revenue of ₹529 and net profit of ₹91.

Item 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar

Revenue and Expenses

Revenue 539 529 526 503 579 547 573 572 622
Expenses 364 397 404 367 400 370 377 393 368

Operating Costs and Margins

EBITDA 175 132 122 137 179 177 195 179 254
Operating Profit % 32.00% 23.00% 23.00% 21.00% 22.00% 21.00% 23.00% 24.00% 29.00%
Depreciation 10 10 9 9 9 9 9 9 9
Interest 0 0 0 0 0 0 0 1 0

Profit and Earnings

Profit Before Tax 165 122 113 127 169 167 186 169 244
Tax 46 31 30 24 33 30 34 46 54
Net Profit 120 91 82 103 137 138 152 123 190
EPS 51.89 39.64 35.69 44.81 59.31 59.79 65.95 53.37 82.78

Sanofi Cash Flow Screener - Liquidity Fundamentals

Screen SANOFI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2024-March, operating activities generated ₹462, and net cash flow was an outflow of ₹111.

Over the same period, investing activities used ₹180 and financing activities used ₹392.

Item 2024-March 2023-March

Cash from Operations and Investing

Operating Activities 462 230
Investing Activities -180 38

Financing and Net Cash

Financing Activities -392 -878
Net Cash Flow -111 -610

Sanofi Shareholding Pattern Screener

See Sanofi shareholding pattern with promoter, FII, and DII holdings. Check Sanofi promoter holding and ownership changes for SANOFI on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 60.40%, foreign institutions 5.64%, domestic institutions 21.13% and the public 10.19%, spread across 75,758 shareholders.

The shareholder count was 75,758 in 2026-Mar, compared with 80,005 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40% 60.40%

Institutional Investors

FII Holding 5.64% 5.69% 5.73% 5.57% 5.61% 5.57% 5.55% 6.11%
DII Holding 21.13% 19.86% 19.41% 23.02% 23.06% 22.29% 21.31% 23.08%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 10.19% 11.38% 11.92% 8.38% 8.33% 9.08% 10.02% 7.97%
Other Holding 2.64% 2.67% 2.54% 2.63% 2.61% 2.67% 2.73% 2.44%
Shareholder Count 75,758 80,005 80,089 68,196 66,790 71,395 75,813 61,849

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Sanofi. Sanofi dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹123.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹123.00 and ₹117.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹123.00 3.83%
2024-March ₹117.00 2.04%
2023-March ₹167.00 2.06%
2022-March ₹570.00 10.15%
2021-March ₹490.00 6.53%
2020-March ₹365.00 4.63%
2019-March ₹349.00 5.58%
2018-March ₹84.00 1.44%
2017-March ₹71.00 1.37%

Sanofi Stock Index Membership - Nifty & Sensex

See which indices include Sanofi stock. Check SANOFI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 9 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED

Sanofi Market Events Screener - Corporate Actions

Get Sanofi corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Sanofi stock events that may affect SANOFI share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Dividend dated November 5, 2026, with a record date of November 5, 2026.

It is followed by Quarterly Result Announcement dated October 29, 2026 and Quarterly Result Announcement dated August 4, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-05 2026-11-05 Dividend ₹ 75.00 /share 15.37%
2026-10-29 2026-10-29 Quarterly Result Announcement NA 1.68%
2026-08-04 2026-08-04 Quarterly Result Announcement NA -0.78%
2026-04-29 2026-04-29 Annual General Meeting NA 6.74%
2026-04-28 2026-04-28 Quarterly Result Announcement NA -3.56%
2026-04-22 2026-04-22 Dividend ₹ 48.00 /share -12.03%
2026-02-25 2026-02-25 Quarterly Result Announcement NA 1.74%
2025-11-07 2025-11-07 Dividend ₹ 75.00 /share -0.03%
2025-10-29 2025-10-29 Quarterly Result Announcement NA -0.56%
2025-07-31 2025-07-31 Quarterly Result Announcement NA -1.24%
2025-05-15 2025-05-15 Annual General Meeting NA 8.52%
2025-05-14 2025-05-14 Quarterly Result Announcement NA 3.02%
2025-04-25 2025-04-25 Dividend ₹ 117.00 /share 29.86%
2025-02-27 2025-02-27 Quarterly Result Announcement NA -5.58%
2024-11-07 2024-11-07 Quarterly Result Announcement NA -6.28%

Sanofi Competitors Screener - Peer Stocks Comparison

Screen SANOFI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 449,036 40.80 61,674 12.69% 11,565 60.77
Divis Laboratories 293,316 87.70 11,067 13.95% 2,568 65.94
Torrent Pharmaceuticals 175,376 84.70 13,886 20.34% 2,138 42.26
Laurus Labs 125,488 94.90 6,868 22.01% 890 55.82
Zydus Life Science 119,900 27.90 27,658 17.64% 5,026 55.22
Dr Reddys Laboratories 116,705 42.00 35,059 3.90% 4,158 73.09
Cipla 114,474 39.20 29,045 2.24% 3,870 62.07
Mankind Pharma 108,424 47.50 14,636 14.85% 1,938 62.66
Aurobindo Pharma 103,355 25.90 34,145 5.56% 3,503 60.69
Lupin 90,173 17.10 29,039 26.75% 5,356 44.73

Sanofi Company Announcements - News & Reports Screener

Screen SANOFI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 19, 2026.

The next most recent announcements are dated October 30, 2026 and October 29, 2026.

Date Update Actions
2026-11-19 Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Update On Show Cause Notice Received From GST Authorities Dated 25Th September 2026 -
2026-10-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-29 Communication Of Tax Deduction At Source On Interim Dividend For The Financial Year 2026 -
2026-10-29 Announcement under Regulation 30 (LODR)-Dividend Updates -
2026-10-29 Record Date For Interim Dividend For The Financial Year 2026 -
2026-10-29 Corporate Action-Board approves Dividend -
2026-10-29 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-29 Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On Thursday 29Th October 2026 -
2026-10-29 Unaudited Financial Results For The Quarter And Nine Months Ended 30Th September 2026 -
2026-10-19 Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter And Nine Months Ended 30Th September 2026; And Declaration And Approval Of Interim Dividend If Any For The Financial Year 2026. -
2026-10-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-07 Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 -
2026-09-29 Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-09-28 Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 -
2026-09-28 Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 -
2026-09-28 Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 -
2026-09-25 Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-09-25 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-25 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-25 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹3,231.80, within a 52-week range of ₹2,772.80 to ₹4,568.80. The P/E ratio is 20.40 and the P/B ratio is 9.00, with earnings per unit of ₹179.46. Market capitalisation stands at ₹7,443.04 Cr and the dividend yield is 2.33%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 2 balance sheet periods, 9 income statement periods, 2 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.